4.6 Letter

Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

Journal

THORAX
Volume 68, Issue 5, Pages 491-492

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2012-203114

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available